<- Go Home

Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Market Cap

CHF 42.1B

Volume

767.4K

Cash and Equivalents

CHF 1.7B

EBITDA

CHF 2.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CHF 5.5B

Profit Margin

55.65%

52 Week High

CHF 101.62

52 Week Low

CHF 82.82

Dividend

0.38%

Price / Book Value

1.95

Price / Earnings

41.49

Price / Tangible Book Value

10.47

Enterprise Value

CHF 45.4B

Enterprise Value / EBITDA

17.61

Operating Income

CHF 1.4B

Return on Equity

4.83%

Return on Assets

2.85

Cash and Short Term Investments

CHF 1.8B

Debt

CHF 5.1B

Equity

CHF 21.6B

Revenue

CHF 9.9B

Unlevered FCF

CHF 1.5B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches